Cargando…

Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants?

BACKGROUND: Viral load is still the marker of choice for monitoring adherence to combined antiretroviral therapy (cART) and confirming the success of HIV treatment. Unfortunately it is difficult to access in many resource-poor settings. We aimed to measure the performance of caregiver reporting adhe...

Descripción completa

Detalles Bibliográficos
Autores principales: Ateba Ndongo, Francis, Warszawski, Josiane, Texier, Gaetan, Penda, Ida, Tetang Ndiang, Suzie, Ndongo, Jean-Audrey, Guemkam, Georgette, Sofeu, Casimir Ledoux, Kfutwah, Anfumbom, Faye, Albert, Msellati, Philippe, Tejiokem, Mathurin Cyrille
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578260/
https://www.ncbi.nlm.nih.gov/pubmed/26391474
http://dx.doi.org/10.1186/s12887-015-0451-3
_version_ 1782391087916122112
author Ateba Ndongo, Francis
Warszawski, Josiane
Texier, Gaetan
Penda, Ida
Tetang Ndiang, Suzie
Ndongo, Jean-Audrey
Guemkam, Georgette
Sofeu, Casimir Ledoux
Kfutwah, Anfumbom
Faye, Albert
Msellati, Philippe
Tejiokem, Mathurin Cyrille
author_facet Ateba Ndongo, Francis
Warszawski, Josiane
Texier, Gaetan
Penda, Ida
Tetang Ndiang, Suzie
Ndongo, Jean-Audrey
Guemkam, Georgette
Sofeu, Casimir Ledoux
Kfutwah, Anfumbom
Faye, Albert
Msellati, Philippe
Tejiokem, Mathurin Cyrille
author_sort Ateba Ndongo, Francis
collection PubMed
description BACKGROUND: Viral load is still the marker of choice for monitoring adherence to combined antiretroviral therapy (cART) and confirming the success of HIV treatment. Unfortunately it is difficult to access in many resource-poor settings. We aimed to measure the performance of caregiver reporting adherence for detecting virological failure in routine practice during the first 2 years after cART initiation in infants. METHODS: PEDIACAM is an ongoing prospective cohort study including HIV1-infected infants diagnosed before 7 months of age between November 2007 and October 2011 in Cameroon. Adherence was assessed using a questionnaire administered every 3 months from cART initiation; the HIV-RNA viral load was determined at the same visits. Virological failure was defined as having a viral load ≥ 1000 cp/mL at 3 and 12 months after cART initiation or having a viral load ≥ 400 cp/mL at 24 months after cART initiation. The performance of each current missed and cumulative missed dose defined according to adherence as reported by caregiver was assessed using the viral load as the gold standard. RESULTS: cART was initiated at a median age of 4 months (IQR: 3–6) in the 167 infants included. The cumulative missed dose showed the best overall performance for detecting virological failure after 12 months of cART (AUC test, p = 0.005, LR + =4.4 and LR− = 0.4). Whatever the adherence reporting criterion, the negative predictive value was high (NPV ≥ 75 %) 12 and 24 months after cART initiation, whereas the positive predictive value was low (PPV ≤ 50 %). CONCLUSIONS: The adherence questionnaire administered by the health care provider to the infants’ caregivers is not reliable for detecting virological failure in routine practice: its positive predictive value is low. However, the cumulative missed dose measurement may be a reliable predictor of virological success, particularly after 12 months of cART, given its high negative predictive value.
format Online
Article
Text
id pubmed-4578260
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-45782602015-09-23 Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants? Ateba Ndongo, Francis Warszawski, Josiane Texier, Gaetan Penda, Ida Tetang Ndiang, Suzie Ndongo, Jean-Audrey Guemkam, Georgette Sofeu, Casimir Ledoux Kfutwah, Anfumbom Faye, Albert Msellati, Philippe Tejiokem, Mathurin Cyrille BMC Pediatr Research Article BACKGROUND: Viral load is still the marker of choice for monitoring adherence to combined antiretroviral therapy (cART) and confirming the success of HIV treatment. Unfortunately it is difficult to access in many resource-poor settings. We aimed to measure the performance of caregiver reporting adherence for detecting virological failure in routine practice during the first 2 years after cART initiation in infants. METHODS: PEDIACAM is an ongoing prospective cohort study including HIV1-infected infants diagnosed before 7 months of age between November 2007 and October 2011 in Cameroon. Adherence was assessed using a questionnaire administered every 3 months from cART initiation; the HIV-RNA viral load was determined at the same visits. Virological failure was defined as having a viral load ≥ 1000 cp/mL at 3 and 12 months after cART initiation or having a viral load ≥ 400 cp/mL at 24 months after cART initiation. The performance of each current missed and cumulative missed dose defined according to adherence as reported by caregiver was assessed using the viral load as the gold standard. RESULTS: cART was initiated at a median age of 4 months (IQR: 3–6) in the 167 infants included. The cumulative missed dose showed the best overall performance for detecting virological failure after 12 months of cART (AUC test, p = 0.005, LR + =4.4 and LR− = 0.4). Whatever the adherence reporting criterion, the negative predictive value was high (NPV ≥ 75 %) 12 and 24 months after cART initiation, whereas the positive predictive value was low (PPV ≤ 50 %). CONCLUSIONS: The adherence questionnaire administered by the health care provider to the infants’ caregivers is not reliable for detecting virological failure in routine practice: its positive predictive value is low. However, the cumulative missed dose measurement may be a reliable predictor of virological success, particularly after 12 months of cART, given its high negative predictive value. BioMed Central 2015-09-21 /pmc/articles/PMC4578260/ /pubmed/26391474 http://dx.doi.org/10.1186/s12887-015-0451-3 Text en © Ateba Ndongo et al. 2015 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Ateba Ndongo, Francis
Warszawski, Josiane
Texier, Gaetan
Penda, Ida
Tetang Ndiang, Suzie
Ndongo, Jean-Audrey
Guemkam, Georgette
Sofeu, Casimir Ledoux
Kfutwah, Anfumbom
Faye, Albert
Msellati, Philippe
Tejiokem, Mathurin Cyrille
Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants?
title Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants?
title_full Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants?
title_fullStr Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants?
title_full_unstemmed Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants?
title_short Could caregiver reporting adherence help detect virological failure in Cameroonian early treated HIV-infected infants?
title_sort could caregiver reporting adherence help detect virological failure in cameroonian early treated hiv-infected infants?
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4578260/
https://www.ncbi.nlm.nih.gov/pubmed/26391474
http://dx.doi.org/10.1186/s12887-015-0451-3
work_keys_str_mv AT atebandongofrancis couldcaregiverreportingadherencehelpdetectvirologicalfailureincameroonianearlytreatedhivinfectedinfants
AT warszawskijosiane couldcaregiverreportingadherencehelpdetectvirologicalfailureincameroonianearlytreatedhivinfectedinfants
AT texiergaetan couldcaregiverreportingadherencehelpdetectvirologicalfailureincameroonianearlytreatedhivinfectedinfants
AT pendaida couldcaregiverreportingadherencehelpdetectvirologicalfailureincameroonianearlytreatedhivinfectedinfants
AT tetangndiangsuzie couldcaregiverreportingadherencehelpdetectvirologicalfailureincameroonianearlytreatedhivinfectedinfants
AT ndongojeanaudrey couldcaregiverreportingadherencehelpdetectvirologicalfailureincameroonianearlytreatedhivinfectedinfants
AT guemkamgeorgette couldcaregiverreportingadherencehelpdetectvirologicalfailureincameroonianearlytreatedhivinfectedinfants
AT sofeucasimirledoux couldcaregiverreportingadherencehelpdetectvirologicalfailureincameroonianearlytreatedhivinfectedinfants
AT kfutwahanfumbom couldcaregiverreportingadherencehelpdetectvirologicalfailureincameroonianearlytreatedhivinfectedinfants
AT fayealbert couldcaregiverreportingadherencehelpdetectvirologicalfailureincameroonianearlytreatedhivinfectedinfants
AT msellatiphilippe couldcaregiverreportingadherencehelpdetectvirologicalfailureincameroonianearlytreatedhivinfectedinfants
AT tejiokemmathurincyrille couldcaregiverreportingadherencehelpdetectvirologicalfailureincameroonianearlytreatedhivinfectedinfants
AT couldcaregiverreportingadherencehelpdetectvirologicalfailureincameroonianearlytreatedhivinfectedinfants